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Abstract
Immunomodulation by nanoparticles, especially as related to the biochemical properties of these unique materials, has
scarcely been explored. In an in vitro model of human immunity, we demonstrate two catalytic nanoparticles, TiO2 (oxidant)
and CeO2 (antioxidant), have nearly opposite effects on human dendritic cells and T helper (TH) cells. For example, whereas
TiO2 nanoparticles potentiated DC maturation that led towards TH1-biased responses, treatment with antioxidant CeO2
nanoparticles induced APCs to secrete the anti-inflammatory cytokine, IL-10, and induce a TH2-dominated T cell profile. In
subsequent studies, we demonstrate these results are likely explained by the disparate capacities of the nanoparticles to
modulate ROS, since TiO2, but not CeO2 NPs, induced inflammatory responses through an ROS/inflammasome/IL-1b
pathway. This novel capacity of metallic NPs to regulate innate and adaptive immunity in profoundly different directions via
their ability to modulate dendritic cell function has strong implications for human health since unintentional exposure to
these materials is common in modern societies.
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Introduction
Nanoparticles (NPs) have become a ubiquitous staple of modern
life, yet researchers have a less than complete understanding of
how these materials affect human health. In fact, it is becoming
increasingly clear that NP species with distinct physiochemical
properties (size, shape, composition, solubility, surface chemistry,
etc.) can interact with body systems in a variety of different ways.
For instance, CeO2 NPs have shown great promise at protecting
tissues from oxidative stress and have been proposed as a modality
to alleviate healthy tissue damage during cancer radiation therapy
[1–3]. On the other hand, metallic NPs have been shown to
negatively impact human health by inducing acute toxicity in the
lung and kidneys [4]. As well, metallic NPs have been found to
induce the production of pro-inflammatory cytokine when
delivered in vivo, which suggests these materials likely can engage
cells of the immune system.
Despite multiple studies detailing the influence of size, solubility,
and surface modification on the biocompatibility of metallic
nanoparticles [5], far fewer reports have directly examined how
the varied physical characteristics of these NPs affect their
interaction with the human immune system. Published work from
our laboratory and other groups has suggested the inflammatory
potential of metallic NPs is inversely proportional to their sizes [6–
8]. Other studies have shown the highly charged surface of some
metallic NPs can facilitate their binding to proteins and other
molecules, leading to macromolecular complex formation and/or
altered protein conformations that can be highly immunogenic
[9]. Some authors have also suggested redox-active surface groups
can directly influence NP interactions with immune cells, but the
impact of these studies is dampened because catalytic NPs were
not directly compared against NPs with opposite redox activities
[10–14]. Indeed, few studies to date have examined whether
antioxidant NPs affect immune function.
Considering the various NP physiochemical properties that
could be considered impactful on immune function, redox activity
is perhaps the most important since catalytic NPs have a unique
capacity to directly modulate reactive oxygen species (ROS). (ROS
are well-established regulators of immune reactions [15].) To
formally address whether catalytic activity affects NP-immune
interactions, we performed a comprehensive examination of the
immunomodulatory potential of two metallic NPs (TiO2 and
CeO2) with opposing redox activities in an in vitro model of human
immunity. This system, which encompasses a number of modular
constructs that permit the evaluation of different facets of
immunity, has been shown in a variety of published studies to
support the generation of responses that reflect known human
in vivo immune profiles against a series of biologic compounds and
vaccines [8,16–26].
Specifically for this study, we have examined the effect of these
unique NP species on human immune cell viability, phenotype,
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uptake, ROS production, and function in the in vitro cell culture
model. Intriguingly, we noted that the reductive CeO2 NPs were
uniquely capable of stimulating DCs to produce IL-10, and when
co-cultured with T cells, triggered a strong TH2-biased/regulatory
cytokine profile. In contrast, oxidative TiO2 NPs induced DCs to
produce IL-12 and polarized T cells toward a TH1-biased
program. As a whole, these data provide evidence that NPs have
the potential to modulate human DC and T helper cell function
with a directionality that is linked to surface redox properties and
suggest a novel basis for modulating immunity via NPs with
tunable surface chemistries.
Results
NP Characteristics
To determine whether surface catalytic activity can affect the
interaction of NPs with the immune system, we performed a
parallel evaluation of the capacity of TiO2 and CeO2 NPs, which
have opposite catalytic activities, to stimulate immune cell
activation in an in vitro model of the human immune system.
The physical properties of the CeO2 and TiO2 NPs included in
this study are discussed in detail in the Materials and Methods section
and are summarized in Table 1. Since we were specifically
interested in understanding whether catalytic activity impacts the
interaction of metallic NPs with the immune system, we first
needed to ensure other physical features of these NPs, such as
agglomeration and purity, did not contribute to changes in
immune function in the in vitro model. As shown in Figure 1, the
CeO2 and TiO2 NPs had a tendency to form soft agglomerates of
10 and 25 nm in diameter, respectively, when cultured for 24-hr in
X-VIVO-15 tissue culture media (serum-free culture media used
in all of the biological assays discussed below). Additionally, we
confirmed both NP preparations were free of contaminating LPS
(EU ,0.05) that could otherwise compromise the outcome of the
subsequent immunoassays (see Figure S1).
DC Cytotoxicity and Maturation Resulting from NP
Treatment
We recognize NPs can potentially interact with a variety of
immune cell populations, but focused our initial evaluation on
DCs since they are involved in many facets of innate and adaptive
immunity. We previously established a dose range for TiO2 NPs in
our in vitro immune cell model [8]; here, we started here by
establish whether assay-derived APCs had a similar tolerance
forCeO2 NPs. Following a 24-hr treatment of the DCs with NPs,
the cells were labeled with a fluorescent apoptotic dye (PO-PRO),
in combination with a vital dye (7-AAD), to discriminate between
live, dead, and apoptotic cells. Unlike TiO2 NPs, which triggered
appreciable apoptosis and death of the cultured DCs in a dose-
dependent manner, we observed no increase in apoptosis or death
in DCs cultured with CeO2 NPs (Figure 2A). It is important to
note that several published articles have shown these NPs do not
interfere with these standard fluorescent readouts [3,8,27,28]. To
further mitigate the risk of NP interference with these assays, the
nanoparticles were diluted in, or delivered, in cultures maintained
in the presence of protein containing media and the cells were
thoroughly washed in protein containing buffers prior to their
acquisition by any instrument. While our findings on TiO2 NP
cytotoxicity in human DCs are consistent with our previous work
and the observations of others using cell lines [8,29–31], we are
unaware of other studies demonstrating a high tolerance of human
DCs for CeO2 NPs.
Metallic NPs have previously been shown to activate/mature
DCs towards an enhanced functional state [8,32]. To determine
whether this DC immunostimulatory potential was driven, at least
in part, by the oxidative activity of TiO2 NPs, we directly
compared DC activation/maturation triggered by TiO2 and the
antioxidant CeO2 particles. As shown in Figure 2B, DCs treated
with as little as 1 mM TiO2 NPs increased their expression of
surface receptors involved in T cell priming/activation (HLA-DR,
CD80 and CD86) and migration (CCR7). TiO2-treated DCs also
upregulated surface CD83, a phenotypic hallmark of DC
maturation, but only at the highest treatment dose (100 mM).
Interestingly, a 24-hour exposure of the DCs to even the highest
dose of CeO2 NPs had almost no effect on CCR7, CD83, CD80,
CD86, or HLA-DR expression levels.
Besides triggering changes in surface marker expression,
maturation stimuli also often cause DCs to produce a variety of
soluble and membrane-bound cytokines that modulate many
facets of innate and adaptive immunity. Indeed, TiO2 particles
stimulated a strong cytokine response from the DCs that was of a
pro-inflammatory slant (Figure 2C, IL-12, TNFa) and consistent
with the phenotype changes highlighted in Figure 2B. Considering
the lack of DC surface marker changes triggered by CeO2
(Figure 2B), we were surprised to find these NPs induced the APCs
to produce significant quantities of the immunoregulatory
cytokine, IL-10. However, the inability of CeO2 NPs to activate
DCs may not be surprising in light of the observation that
antioxidants, such as N-acetylcysteine, do not induce DC
maturation, and to some extent, have even been shown to
mitigate DC maturation [33,34]. Furthermore, some published
studies have also shown chemical antioxidants, like phenyl N-tert-
butyl nitrone, have the propensity to induce IL-10 production in
cultured DCs [35,36].
Redox Potential as a Regulator of DC Activation State
Considering evidence suggesting oxidative stress can result in
cytotoxicity and inflammation [37], we suspected the differential
responses generated by TiO2 and CeO2 NPs might be explained
by their opposite surface reactivity. To rule out the possibility that
these distinct responses could be explained simply by the
differential uptake of TiO2 and CeO2 NPs by DCs, we used a
highly sensitive inductively coupled plasma-mass spectroscopy
(ICP-MS) technique [38,39] to examine whether the NPs were
localized within the treated DCs. With this technique, we were
able to rule out uptake as an explanation for the results of Figure 2
since Figure 3 shows uptake is dose-dependent and detectable by
ICP-MS at concentrations above 50 mM for both NPs species.
While previous studies examined APC-mediated uptake of TiO2
and CeO2 at a much higher dose ranges than those used in the
current study [40–43], it should be noted that we used a lower
treatment dose range because we wanted to ensure that the
immune cells remained viable for subsequent functional assess-
ments.
As noted in the Introduction section, catalytic NPs have a unique
capacity to directly modulate reactive oxygen species (ROS).
Given our findings thus far, and the known redox activity these
materials possess, we felt it necessary to examine ROS as a possible
mechanism to explain the unique and disparate DC activation/
maturation profiles triggered by TiO2 and CeO2 NPs. Towards
this goal, we analyzed intracellular oxidative stress levels in NP-
treated DCs with a specific dye, DCF-DA, which fluoresces upon
contact with ROS. Figure 4A reveals that TiO2 NPs induced
human DCs to generate ROS in a dose-dependent manner and at
levels comparable to the positive control, H2O2. In contrast, CeO2
NPs triggered little or no ROS in treated DCs and were even
capable of blunting ROS production in DCs treated with H2O2
Immunomodulatory Nanoparticles
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Figure 1. CeO2 NPs and TiO2 NPs appear as soft agglomerates when diluted in X-VIVO 15 serum free media. High resolution
transmission electron microscopy of (A) CeO2 NPs indicates a composition of individual 3–5 nm nanocrystallites and (B) 7–10 nm TiO2(anatase) NPs.
The average size distribution of (C) CeO2 and (D) TiO2 NPs were measured using dynamic light scattering following a 24 hour incubation of the
prepared NP solutions (each at 500 mM) in X-VIVO 15. Selected area electron diffraction patterns (SAEDP) of the CeO2 (E) and TiO2 NPs (F) were carried
out using a high-resolution transmission electron microscope (HRTEM) equipped with a FEI Tecnai F30 having an energy-dispersive X-ray (EDX)
analyzer. The SAED pattern of CeO2 NPs, where A(111), B(200), C(220) and D(311) correspond to the different lattice planes of CeO2 and confirms the
crystalline structure of this material. Similarly, the SAED pattern of TiO2 also confirms the crystalline nature of the material since the A(101), B(004),
Immunomodulatory Nanoparticles
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(Figures 4A and 4B). (It should be noted that H2O2-induced ROS
production was unaffected by TiO2 treatment.).
Although ROS can act through a variety of downstream
pathways to regulate/potentiate immune reactions, perhaps its
most important feature is its ability to activate innate danger
sensors, such as the NLRP3 inflammasome [44]. Since the
detection of IL-1b has been routinely used as a readout of NLRP3
inflammasome activation [44], we used this cytokine as an indirect
measure of whether TiO2 and/or CeO2 NPs activate the NLRP3
inflammasome in human DCs. Based on past studies demonstrat-
ing TiO2 NPs activate the NLRP3 inflammasome in mice [44], we
were not surprised to find DCs treated with these NPs were
stimulated to secrete heightened quantities of IL-1b. In subsequent
studies, we showed the selective NLRP3 inhibitor, glybenclamide
(50 mM), abolished IL-1b production in these cultures. This
provides further evidence that TiO2 NPs act through the NLRP3
inflammasome to induce IL-1b production (Figure 4C). In stark
contrast to these results, we found CeO2 NPs triggered no IL-1b
production by the cultured DCs (Figure 4C), which further
supports our earlier conclusions that these anti-oxidant NPs induce
a null or anti-inflammatory response in DCs.
NPs Drive CD4+ T Cell Proliferation and TH1/TH2
Polarization
Following our finding that CeO2 and TiO2 provide human DCs
with distinct stimulatory/maturation cues, we questioned whether
these differences would, in turn, translate into unique patterns of T
cell responses resulting from stimulation with the NP-treated DCs.
Prior to addressing this issue, we first investigated whether NPs
directly activate lymphocytes in a 5-day stimulation assay where T
cell proliferation serves as the primary readout of the response. To
our surprise, TiO2 had a modest immunostimulatory effect on the
T cells, as demonstrated by their capacity to induce an increase in
the divided (CFSE-low) lymphocyte population over the untreated
control. Furthermore, the co-administration of TiO2 NPs with the
mitogens, PHA and PMA, synergistically increased the prolifer-
ative response (Figure 5). CeO2 NPs alone did not induce
measurable T cell proliferation but, interestingly, did reduce the
proliferative response when added with the mitogen cocktail
(Figure 5). Of note, neither of the particle types affected the
viability of the T cells over a broad dose range (see Figure S2). As
an additional measure to investigate the stimulatory effect these
NPs have on T cells, we examined the expression levels of CD95
(FasR), which becomes upregulated under stress or disease
conditions and is part of the programmed death response [45].
The expression of CD95 was unaffected by either NP treatment
(see Figure S3). However, treatment with TiO2 NP in addition to
the mitogen cocktail, PHA/PMA, revealed the capacity for TiO2
NPs to drive a much stronger level of CD95 expression as
compared to CeO2 NP and mitogen treated TH cells (Figure S3).
While this evidence doesn’t tell us precisely how these NPs are
interacting with T cells, the NPs are affecting T cell phenotype and
function as measured by these assays.
To better define the impact of catalytic NPs on human adaptive
immunity, we directly examined the capacity of NP-treated DCs
to stimulate naı¨ve T cell responses using our in vitro model of
human immunity. With this approach, the engagement of TCR by
foreign HLA class II molecules on the surface of mismatched DCs
is sufficient to induce the activation of the lymphocytes in an
antigen-independent fashion. Here, DCs were left untouched
(iDC), matured with a maturation cocktail (mDC, positive control),
or primed with CeO2 or TiO2 NPs before being co-cultured with
allogeneic CD4+ T cells. After 5 days, the cells and culture
supernatants were harvested for evaluation by flow cytometry (cell
viability and proliferation) and Bio-Plex assay (cytokine produc-
tion).
Although the CeO2 NP-treated DCs had little influence on
allogeneic naı¨ve CD4+ T cell proliferation, TiO2 NP-treated DCs
boosted the magnitude of the proliferative response (Figure 6). As
well, we observed that both particles triggered cytokine responses,
but the profiles were nearly opposite: TiO2 NPs-pulsed DCs
triggered a pro-inflammatory TH1-biased cytokine response (IL-2,
IFN-c) while DCs pulsed with CeO2 NPs induced a naı¨ve T cell
response dominated by TH2 cytokines (IL-4, IL-5, and IL-10) that
are predominately anti-inflammatory and promote humoral-
skewed responses. Beyond their capacity to participate in the
induction of a TH2-biased T cell response, the CeO2 NPs were
even capable of eliciting the production of IL-4, IL-5 and IL-10 in
T cell co-cultures stimulated with a strongly Th1-biasing mitogen
(Figure 7). While we might have anticipated that a well-described
pro-inflammatory particle like TiO2 could drive a type 1 immune
response, the response profile induced by CeO2 NPs, including IL-
10 secretion by DCs (Figure 2) and TH2 polarization (Figure 6 and
7),suggest a unique functional property of metallic antioxidant NPs
that, to our knowledge, has not previously been described.
C(200) and D(211) rings correspond to the different lattice planes of the NPs. Surface oxidation state of CeO2 and TiO2 NPs were calculated from the
XPS spectrum of Ce3d (G) and Ti 2p (H). (G) Deconvoluted peaks at 882.36 eV, 898.20 eV, 901.23 eV, 907.03 eV, and 916.64 eV are attributed to a Ce4+
oxidation state (light gray solid line) while 880.22 eV, 885.24 eV, 899.16 eV and 903.68 eV are the characteristic peaks of a Ce3+ oxidation state (dark
gray solid line). Intensity of the peaks for Ce3+ and Ce4+ were estimated, and Ce3+/Ce4+ ratio on the surface of the nanoparticles were calculated and
found to be 1.66. (H) In the case of TiO2 NPs, the binding energies of Ti 2p3/2 and Ti 2p1/2 are at approximately 458.84eV and 464.62 eV, respectively.
The difference of ,5.8 eV in both peaks indicates a valence state of +4 for Ti on the surface of the NPs.
doi:10.1371/journal.pone.0062816.g001
Table 1. Physical properties of nanomaterials included in this study.
Particles
Preparation
Method Diameter nm)
DLS Peak
intensity
BET Surface
(m2/g)
Zeta Potential
(mV)* Surface Reactivity Crystal Structure
TiO2 HT-WCS
1 7–10{ 25 nm 239 29.8460.19 Oxidative Anatase
CeO2 RT-WCS
2 3–5{ 10 nm 90 210.0161.50 Reductive Fluorite
1High temperature wet chemical synthesis.
2Room temperature wet chemical synthesis.
*Zeta potential after 24 hrs in X-VIVO 15 culture media.
{Average diameter of NPs, expressed as mean size 6 SD nm.
doi:10.1371/journal.pone.0062816.t001
Immunomodulatory Nanoparticles
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Discussion
Despite the emergence and rapid adoption of NPs into modern
life, a paucity of data exists on how these materials influence
human physiology, including the immune system. In an earlier
publication from our laboratory, we showed particle size had a
profound impact on the ability of TiO2 NPs to induce
inflammation in an in vitro model of human immunity [8]. In the
current study, we questioned whether other physiochemical
features of NPs, specifically surface reactivity, might also influence
the immunomodulatory potential of NPs. Towards this goal, we
employed the same in vitro model employed above to examine
whether oxidative TiO2 and anti-oxidative/reductive CeO2 NPs
have altered capacities to influence human immune reactions.
In a series of experiments aimed at examining the impact of
these NPs on innate responses, we demonstrated that TiO2 NPs
push human DCs towards a more activated/pro-inflammatory
state while CeO2 NPs triggered a more anti-inflammatory profile
in these cells. Given these observations, we were not surprised to
see the NP-treated APCs, in turn, triggered nearly opposite T
helper cell response profiles (CeO2 promoted a TH2 profile while
TiO2 lead to a TH1 pattern). Our current results with TiO2 NPs
were consistent with our published work and reports by others
showing these NPs can induce oxidative stress and inflammation
[8,46,47]. On the contrary, we did not anticipate CeO2 NPs would
induce such a pronounced TH2-biased (IL-4, IL-5 and IL-10) T
cell response and even blunt mitogen-induced TH1 (IL-2, IFNc,
and TNFa) cytokine production. Though the overall profile of
cytokines produced by TH cells stimulated with CeO2-stimulated
DCs is consistent with a TH2 profile, it should also be noted that
the strong IL-10 response might be reflective of Treg induction in
these cultures. Additionally, we examined additional cytokines/
chemokines which were not activated in response to treatment
(See Methods section). Our preliminary results did not indicate
CeO2-stimulated cultures yield a higher frequency of Treg cells, but
further experimentation will be necessary to fully investigate this
possibility.
To date, few studies have detailed the capacity of NPs to
polarize TH cell response and none have shown the pronounced
NP-induced TH biasing demonstrated here. For example, Liu
et al. showed poly-hydroxylated metallofullerenol NPs could
induce TH cytokine responses, but only in a mixed fashion (both
TH1 and TH2 cytokines were produced). In a second example,
PLGA-NPs were shown to push TH cells towards a specific
cytokine profile, but only in cases where the NPs were conjugated
to known TH biasing peptides [48,49]. This unique and
pronounced TH response polarization resulting from metal-oxide
(TiO2 and CeO2) NP treatment could possibly be explained by the
differences in the capacities of the two NP species to regulate ROS
production, particularly since ROS can function as a second
Figure 2. CeO2 NPs trigger human DCs to produce significant amounts of IL-10. (A) Dendritic cells were exposed to the indicated
concentrations of NPs for 24 hrs and assessed for viability using 7-AAD and apoptosis by Po-Pro staining. As negative and positive controls, DCs were
left untouched (mock) or treated with 1 mg/ml Fas ligand (FAS), respectively. Bar graph data are plotted as mean 6SD. (B) Dendritic cells were
exposed to the indicated concentrations of NPs for 24 hours and assessed for phenotypic expression of human DC markers, as indicated, by flow
cytometric analysis. (C) Supernatants from DCs stimulated with 1 mM of either NPs were examined for soluble cytokines by Bio-Plex assay. Each dot on
the scatter plot represents the signal for an individual donor; Data are mean+/2SD, n = 10. A paired t-test was performed: **p,0.005, ***p,0.0005
versus TiO2 or CeO2 group; uup,0.005, uuup,0.0005 versus mock group.
doi:10.1371/journal.pone.0062816.g002
Immunomodulatory Nanoparticles
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messenger and modulator of immunity [15,50–52]. Going a step
further, it is interesting to speculate the anti-oxidant redox activity
of CeO2 NPs triggers significant IL-10 production by the DCs that
ultimately leads to the strong IL-10 response by activated T cells in
the DC/T cell cultures since this cytokine is a well-established
regulator of TH cell differentiation [53–55]. This hypothesis is
consistent with prior studies showing ROS-generating materials,
like TiO2 NPs, trigger downstream pro-inflammatory effects and
antioxidants prevent the initiation of the innate immunity in LPS-
stimulated macrophages, as evidenced by the suppression of pro-
inflammatory cytokine (TNF-a, IL-1b) secretion by the treated
cells [56,57]. As well, it is supported by another study showing
palladium NPs, a reducing agent with anti-oxidative properties
similar to CeO2 NPs, can trigger IL-10 production by human
peripheral blood mononuclear cell (PBMCs) [58]. It should be
noted that our observations suggesting NPs modulate immune
function through an ROS pathway does not preclude the
possibility that the particles act on APCs via other mechanisms.
While no current in vitro culture model can replicate all the
intricacies and variables of the in vivo environment, we have
assessed these materials to the best of our capacities using our
in vitro model which has provided meaningful pre-clinical infor-
mation on human immune responses shown to be reflective of
human responses in prior publications [59,60]. However, since
these materials are unable to be tested in a clinical setting, we are
in the process of validating our in vitro results through the use of a
murine model. Unfortunately, such evaluations are very complex
and require a great deal of consideration across a number of
experimental parameters including dosing schema, diluent, route
of administration, number of treatments, kinetics, (disease) model,
and possible readouts.
We speculate the distinct immunostimulatory potentials ob-
served between CeO2 and TiO2 are likely explained by the distinct
manner in which these materials are able to absorb photons. Here,
the materials differ in that the photons have a tendency to migrate
to the surface of TiO2 NPs, where they are free to react with
oxygen, water, or hydroxyls to form free radicals [61]. On the
other hand, the CeO2 NPs absorb these free photons where they
remain isolated from the outside environment [61]. In fact, this
chemistry leads to their distinct oxidant/antioxidant properties, as
illustrated in Figure 4A and 4B, where ROS production by DCs
increased linearly with TiO2 NP dose, but remains absent in CeO2
NPs-treated cultures. Moreover, CeO2 actually inhibited ROS
production induced by H2O2 in a dose-dependent manner, which
suggests this NP species is a very potent anti-oxidant.
Taken as a whole, the results of this study suggest differences in
surface reactivity can profoundly affect how metallic NPs interact
with the human immune system (Table 2). Specifically, these data
suggest low-dose exposure of human immune cells to redox-active
NPs have the propensity to modulate human innate and adaptive
immunity, i.e, DC activation and primary CD4 T helper cell
differentiation state. For this reason, CeO2 NPs (and perhaps other
anti-oxidant moieties) might offer researchers a unique opportu-
nity to push adaptive responses in a focused direction away from a
TH1 bias and towards a TH2/Treg bias. Alternatively, TiO2 might
serve as a potent Th1-promoting treatment during prophylaxis or
disease treatment. On the contrary, the immunomodulatory
potential of NPs could pose a considerable health risk if
encountered in an uncontrolled environment. Specifically, the
TH-skewing potential of NPs could possibly translate into effects
on general inflammatory diseases, airway hyperresponsiveness,
asthma, and autoimmunity. With further study, features like
catalytic behavior may potentially be exploited for engineered NPs
to meet a particular goal, such as enhancing immune responses
during vaccination or mediating immune tolerance against
allergies or autoimmune disease.
Materials and Methods
Subjects
This study included PBMC blood product from 10 healthy
donors. This study was approved by the ethics committee of the
Chesapeake Research IRB. Full documentation of application
process, orientation attendance, and signed written informed
consent forms were obtained from all donors prior to their
participation and the study procedures were conducted in
accordance with the Declaration of Helsinki (protocol CRRI
0906009). All applicants have met guidelines set forth in the
approved IRB protocol, which includes (but is not limited to)
restrictions regarding general health, disease screening, weight,
and age. Blood collections were performed at Florida’s Blood
Centers (Orlando, FL), a state/federally regulated blood collection
center, using standard techniques approved by their institutional
review board. The PBMCs collected under our donor program are
collected, stored, and later used for various immunological
research projects at Sanofi Pasteur VaxDesign Campus. The
donors’ PBMCs used in this study were randomly selected from
our cryo-bank.
Figure 3. Human DCs have the capacity to internalize CeO2 and
TiO2 NPs. Cytokine-derived human DCs were pulsed for 24 hours with
the listed dosing range of either NP. The DCs were harvested and
washed several times before examination by inductively coupled
plasma-mass spectroscopy (ICP-MS) for metal analysis and detection
(ppb). Each sample was examined for the presence of both cerium
(bottom) and titanium (top) as an assay detection control. Ten donors
were analyzed in total. The paired t-test was used for statistical analyses.
n = 10; **p,0.005, ***p,0.0005 versus mock group.
doi:10.1371/journal.pone.0062816.g003
Immunomodulatory Nanoparticles
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Reagents
Bacterial lipopolysaccharide (LPS), phytohaemagglutinin
(PHA), and phorbol 12-myristate 13-acetate (PMA) were obtained
from Sigma (St. Louis, MO). ROS levels were determined using
the fluorescent label, 2-,7-dichlorodihydrofluorescein diacetate
(DCF; Sigma). Glybenclamide was purchased from Sigma and
used as an NLRP3 inflammasome inhibitor [62].
Synthesis of NPs
TiO2 NPs were synthesized by wet chemical synthesis as
previously described [8]. Briefly, a 50:50 mixture of ultrapure
ethanol (Sigma) and deionized water (18.2 M) was boiled to reflux.
The pH of the boiling solution was adjusted to 3.0 with the
addition of 1 N HCl. Titanium isopropoxide (Sigma) was added
slowly to the refluxing mixture, which precipitates immediately to
a white solution. The solution was then stirred at 85uC for 4 hours.
The white solution was then cooled to room temperature and
washed several times with ethanol until dry. The final preparation
was mostly anatase (partially amorphous) TiO2. CeO2 NPs were
synthesized using wet-chemical synthesis as described previously
[63]. Briefly, cerium nitrate hexahydrate was dissolved in
deionized water (18.2 MV). A stoichiometric amount of hydrogen
peroxide was added as an oxidizer and immediately resulted in the
formation of cerium oxide NPs. The NP powder was obtained by
washing the precipitate of CeO2 NPs several times with acetone
and water to remove the surfactant used in the synthesis process.
The solution was aged further to allow the slow reduction of
surface cerium from 4+ oxidation state to 3+ oxidation state in
acidic medium by maintaining the pH of the suspension below 3.5
with nitric acid. Nanoparticle treatments investigated in this study
are reported in molarity and the mass per volume is indicated in
parenthesis as follows: TiO2 - 0.1 mM (0.0079 mg/mL), 1.0 mM
(0.0798 mg/mL), 10 mM (0.798 mg/mL), 50 mM (3.993 mg/mL),
100 mM (7.986 mg/mL), 500 mM (39.93 mg/mL), 1000 mM
(79.86 mg/mL); CeO2 - 0.1 mM (0.0172 mg/mL), 1.0 mM
(0.172 mg/mL), 10 mM (1.72 mg/mL), 50 mM (8.605 mg/mL),
100 mM (17.2 mg/mL), 500 mM (86.05 mg/mL), 1000 mM
(172.11 mg/mL).
Figure 4. Redox activities of nanomaterials modulate ROS production and NLRP3 inflammasome activation in DCs. (A) Human DCs
were cultured in the absence or presence of the indicated doses of TiO2 or CeO2 NPs for 24 hr prior to being examined for their production of ROS. (B)
DCs were cultured in the presence of cerium oxide at various concentrations for 8 hours and then H2O2, an inducer of ROS, was added for the
remainder of the 24 hour incubation period. Oxidative stress was measured by DCF-DA staining of ROS. Six donors where examined in total. (C) DCs
were stimulated for 24 hours with Alhydrogel (AlHy, 150 mg/ml) as a positive control for NLRP3 activation. Alternatively, TiO2 NPs or CeO2 NPs were
delivered at 1 mM to the cultures for 24 hours prior to being measured for the presence of IL-1b in the presence or absence of NLRP3 inhibitor,
glybenclamide (50 mM). Each data point is representative of an individual donor, n = 10. A paired t-test was performed: **p,0.005, ***p,0.0005
versus mock group.
doi:10.1371/journal.pone.0062816.g004
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Figure 5. TiO2 and CeO2 NPs induce differential T cell responses. CD4
+ T cells were labeled with the division-sensitive dye, CFSE, and cultured
in the presence or absence of the indicated stimuli (NPs: 10 mM, PHA: 1 mg/mL, PMA: 50 ng/mL) for 5 days. Thereafter, the cells were harvested and
examined for proliferating (CFSE-low) cells by flow cytometry. Histograms are representative plots from one of the five donors investigated, CFSE
plotted on x-axis as a percent of maximum (y-axis).
doi:10.1371/journal.pone.0062816.g005
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Characterization
TiO2 and CeO2 NPs were analyzed using high-resolution
transmission electron microscopy (HRTEM; Philips 300 TECNAI
operated at 300 kV) to confirm their shape, size, and morphology.
The HRTEM samples were prepared by dipping a polycarbon-
coated copper grid into a dilute suspension of NPs dispersed in
acetone. The surface area of the NPs were measured based on
physical adsorption of ultra-high purity nitrogen gas at liquid
nitrogen temperature using a Brunauer-Emmett-Teller (BET) Nova
4200e instrument manufactured by Quantachrome (Boynton
Figure 6. CeO2 and TiO2 NP-primed DCs differentially modulate CD4
+ T cells proliferation. Naı¨ve CD4+ T cells were isolated and labeled
with the division-sensitive dye, CFSE. (A) The CFSE-labeled T cells were then co-cultured for 5 days with immature DCs (iDCs; untreated), matured DCs
(mDCs; treated overnight with TNFa and PGE2), or NP treated DCs (24 hour treatment with the indicated nanomaterial described on the x-axis). (B)
Thereafter, the cells were harvested and examined for proliferating (CFSE-low; left panel) and activated (CD4+CD25+; right panel) T cells by flow
cytometry, n = 10. See Table S1 and Table S2 for Tukey’s honest significance test for pairwise comparisons of each treatment.
doi:10.1371/journal.pone.0062816.g006
Figure 7. CeO2 and TiO2 NPs induce naı¨ve human CD4
+ T cells towards distinct cytokine profiles. DCs were treated with NPs (10 mM) for
24 hours prior to being harvested, washed and co-cultured with a mismatched (allogeneic) donor purified T cells over a 5-day incubation period. T
cells were cultured with PHA (1 mg/mL), where indicated. Supernatants from the T cell stimulation assays were examined for TH1 and TH2 associated
cytokines by Bio-Plex array. Each dot on the scatter plot represents the signal for an individual donor. Five donors were examined in total. A paired t-
test was performed: *p,0.05, **p,0.005, ***p,0.0005 versus TiO2 or CeO2 group; up,0.05, uup,0.005, uuup,0.0005 versus mock group.
doi:10.1371/journal.pone.0062816.g007
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Beach, FL). The samples were prepared in quartz tubes and
degassed at 240uC in vacuum for 3 hours before actual
measurement. The size of the NPs was determined by the
dynamic light scattering method using the Zetasizer Nano
manufactured by Malvern Instruments (Worcestershire, UK).
The physical characterization of the materials is reviewed in
Figure 1 and summarized in Table 1.
Evaluation of Endotoxin Contamination
All NP preparations were confirmed negative for the presence of
endotoxin contamination using the FDA-approved Endosafe LAL
colorimetric and turbidimetric assay system (Charles River
Laboratories, Wilmington, MA). This data is shown in Figure S1.
PBMC Isolations
Within hours following their harvest from the donor, the
enriched leukocytes were centrifuged over a Ficoll-plaque PLUS
(GE Healthcare, Piscataway, NJ) density gradient [24,25]. PBMCs
at the interface were collected, washed, and cryopreserved in
IMDM media (Lonza, Walkersville, MD) containing autologous
serum and DMSO (Sigma-Aldrich, St. Louis, MO).
Generation of Cytokine-Derived DCs
DCs used throughout the assays of this study were prepared
using our previously published methodology [25]. Briefly, mono-
cytes were purified from total PBMCs by positive magnetic bead
selection (Miltenyi Biotec, Cologne, Germany) and cultured for 7
days in X-VIVO 15 (Lonza) serum-free media supplemented with
GM-CSF (R&D Systems, Minneapolis, MN) and IL-4 (R & D
Systems). In all assay conditions described below, treatments were
delivered on day 6 followed by harvesting on day 7 for
incorporation into the various assays.
ROS Determination
DCs were treated with serial dilutions of TiO2 NPs and CeO2
NPs for 24 h. Subsequently, the cultures were washed and treated
at room temperature for 30 min with DCF at a final concentration
of 10 mM. The cells were washed of excess dye with DPBS,
harvested using cell-dissociation solution (Sigma), and washed
again in DPBS. Fluorescence in the FITC channel from absorbed
and oxidized DCF (indicative of peroxide levels) was analyzed by
flow cytometry using an LSR II (Becton Dickinson). FlowJo
software (Treestar, Ashland, OR) was used for data analysis.
DC Phenotype/cytokine Analysis
For flow cytometry analysis of surface molecule expression, DCs
were washed in fluorescence-activated cell sorting buffer (FACS
Buffer). Fc receptors were blocked with mouse serum (Jackson
ImmunoResearch, West Grove, PA) to prevent nonspecific
binding. DCs were then stained with a vital dye (LIVE/DEADH;
Invitrogen). (Conversely, for determination of apoptosis DCs were
stained with Po-Pro/7-AAD (Invitrogen) at the end of the surface
antibody staining.) After washing away excess viability dye with
PBS, the cells were then incubated with the appropriate antibody
cocktail. The antibodies used in the staining panels include HLA-
DR, CD14, CD40, CD80, CD83, CD86, CD19, CD3, CD209,
and CCR7. All antibodies we purchased from eBioscience (San
Diego, CA) with the exception of CD209 (BD Pharmigen, San
Diego, CA). Following staining, cells were washed in FACS buffer
and immediately acquired on a BD LSRII flow cytometer (Becton
Dickinson), and data analyzed using FlowJo software V9.2 (Tree
Star).
Supernatant from the treated DC culture wells and DC:T cell
co-cultures were collected and analyzed for cytokine production by
means of the Bio-Plex Multiplexing array system (Bio-Rad,
Hercules, CA) as previously described [8]. The Bio-Plex array
used in this study included: IL-1ra, IL-1b, IL-2, IL-4, IL-5, IL-6,
IL-7, IL-9, IL-10, IL-13, IL-15, IL-17, IFN-gamma, eotaxin, G-
CSF, GM-CSF, MIP-1a, MIP-1b, PDGF-BB, RANTES, TNF-
alpha, and VEGF.
NP Uptake by DCs
Samples treated for 24-hrs with TiO2 or CeO2 NPs were
harvested, washed and placed in 70% nitric acid overnight and
then microwaved to digest the cellular material. The temperature
of the cell harvest was steadily increased to 200uC over a 20-mins
period and held constant at 200uC for an additional 20 minutes.
The samples were then boiled down to less than 1 ml and
reconstituted in water to an exact volume of 10 ml. Titanium and
cerium levels were assessed using inductively coupled plasma mass
spectroscopy (ICP-MS) using published techniques that have been
optimized to minimize the possibility of surface-bound or
aggregated NPs from being carried over from the washing steps
[39].
CD4+ T Cell Proliferation Assay
Human CD4+ T cells were isolated from PBMCs by positive
selection using EasySEP CD4+ T cell isolation kit II (Stem Cell
Technologies, Vancouver, Canada). The purified CD4+ T cells
were then carboxyfluorescein succinimidyl ester (CFSE)-labeled to
follow proliferation and incubated either in the presence of the
described NPs with or without PHA/PMA or without stimulation
and left in culture for 5 days. The cells were harvested, and
examined by flow cytometry using LIVE/DEAD AQUA and
CFSE (Invitrogen) and antibodies specific for CD4 and CD25
(eBioscience) by flow cytometry.
In vitro Model of Human Immunity
Dendritic cells were generated using a 3-dimensional tissue
engineered construct described previously [8,24]. These DCs were
either untouched, matured with a cocktail of TNFa and PGE2 as
described previously as a positive control [24], or were exposed to
various doses of NPs for 24 hours prior to being harvested. The
treated DCs were harvested and added at an optimized ratio of
1:400 to allogeneic naı¨ve CD4+ T cells isolated using EasySEP
CD4+ T cell isolation kit II (Stem Cell Technologies) and labeled
Table 2. Immunological and biochemical effect of nanomaterials investigated.
Particles
Surface
Reactivity Cytokines induced
Inflammasome
induction T cell proliferation TH polarization ROS
TiO2 Oxidizing Proinflammatory Yes Modest TH1 Generator
CeO2 Reducing Anti-inflammatory No None TH2 Scavenger
doi:10.1371/journal.pone.0062816.t002
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with CFSE (Invitrogen). After five days the cultures were harvested
and stained for CD25, CD3, CD4, (eBioscience) and Live/Dead
Aqua for viability (Invitrogen) and then acquired by flow
cytometry using BD Pharmingen’s LSR II as described above.
Additionally, supernatant’s were collected and examined for
cytokine secretion by Bio-Plex array as previously described
above. Here, PHA/PMA (1 mg/mL; 50 ng/mL) was used not only
as a positive control for cytokine production, but also added in
combination with NP-treated DC co-cultures where described.
Flow Cytometry, Data Plotting and Statistical Analysis
Cytometry data was analyzed using FlowJo software V9.2 (Tree
Star). Each experiment was repeated with at least three donors or
more, as described in the figure legends and plotted as an average
(with S.D.) or displaying each data point. Analyzed statistical
results were determined using a paired Student’s t-test. Statistical
significance was considered at p,0.05 or otherwise stated in figure
legend. Tukey’s honest significance test was employed, in
conjunction with an ANOVA, to determine if the treatment
groups (between CeO2 and TiO2) are significantly different from
each other. All graphs and biostatistics were produced using
GraphPad Prism software V5 (La Jolla, CA).
Supporting Information
Figure S1 Endotoxin levels of CeO2 and TiO2 NP
measured ,0.05 EU/mL. The TiO2 and CeO2 NPs were
diluted to 100 mM concentrations in sterile endotoxin-free water.
The diluted preparations were then examined for endotoxin levels
using an automated FDA-licensed endotoxin detection system by
Charles Rivers Laboratories. No detectable (ND) levels of
endotoxin were observed in the NP preparations. Three
independent samples were run to generate average bar with S.D.
(TIF)
Figure S2 T cells remain viable following treatment
with NPs. Freshly isolated CD4+ T cells were cultured in the
absence or presence of TiO2 NPs (1 mM), CeO2 NPs (1 mM),
PHA/PMA (as a positive assay control), or combinations of either
NP with PHA/PMA. After 5 days, the cultures were harvested and
stained with the viability dye (LDA) and examined by flow
cytometry. The % LDA negative represents the fraction of live
cells in the culture. Each column is the average of 5 donors plotted
with S.D.
(TIF)
Figure S3 CeO2 mediates cellular stress induced by
mitogen control as indicated by reduced CD95 expres-
sion. Freshly isolated CD4+ T cells were cultured in the absence
or presence of TiO2 NPs (1 mM), CeO2 NPs (1 mM), PHA/PMA
(as a positive assay control), or combinations of either NP with
PHA/PMA. After 5 days, the cultures were harvested and stained
with anti-CD95 and assessed by flow cytometry. The mean
fluorescent intensity of the CD95 expression was calculated in
FlowJo and plotted. Each column is the average of 5 donors
plotted with S.D. (p,0.05 where noted).
(TIF)
Table S1 Statistical analysis of Figure 6 A. Tukey’s honest
significance test was employed, in conjunction with an ANOVA,
to determine if the treatment groups (between CeO2 and TiO2)
are significantly different from each other in relation to CFSE
fluorescence.
(DOCX)
Table S2 Statistical analysis of Figure 6 B. As in Table S1,
Tukey’s honest significance test was employed, in conjunction with
an ANOVA, to determine if the treatment groups (between CeO2
and TiO2) are significantly different from each other in relation to
CD25 expression.
(DOCX)
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